Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy. [electronic resource]
- International journal of molecular sciences Apr 2019
Publication Type: Journal Article
1422-0067
10.3390/ijms20081831 doi
Aged Aged, 80 and over Androgen Antagonists--therapeutic use Androstenes--pharmacology Benzamides Biomarkers, Tumor Cell Line, Tumor Cytokines--blood Drug Resistance, Neoplasm Humans Immunomodulation--drug effects Lymphocyte Count Male Middle Aged Myeloid-Derived Suppressor Cells--immunology Nitriles Phenylthiohydantoin--analogs & derivatives Prostatic Neoplasms--drug therapy T-Lymphocytes--immunology